Drug Database
Back to search

Poland· PL-100439000

Solcoseryl

A sonstige buccale therapeutika product containing bezbiałkowy dializat z krwi cieląt + polidocanolum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.

ATC A01AD11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSolcoserylATCA01AD11REGISTER NO.PL-100439000PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bezbiałkowy dializat z krwi cieląt + polidocanolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sonstige buccale therapeutika is registered in 7 of 19 countries.

Countries holding a registration under ATC A01AD11 (sonstige buccale therapeutika), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search sonstige buccale therapeutika products by name

Sonstige buccale therapeutika · ATC A01AD11

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Bezbiałkowy dializat z krwi cieląt + Polidocanolum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
A01AD11
ATC class
Sonstige buccale Therapeutika
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991435868

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A01AD11

Sonstige buccale therapeutika, as other registers publish it.

All sonstige buccale therapeutika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8ef33da5-bd8a-4c86-a191-57fee72be29d
GET /v1/drugs/8ef33da5-bd8a-4c86-a191-57fee72be29d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pasta do stosowania w jamie ustnej",
  "source": "urpl",
  "strength": "(2,125 mg + 10 mg)/g",
  "packaging": "05909991435868 ¦ OTC ¦ 137144\n1 tuba 5 g",
  "substance": "Bezbiałkowy dializat z krwi cieląt 2.125 mg/g + Polidocanolum 10 mg/g",
  "common_name": "Bezbiałkowy dializat z krwi cieląt + Polidocanolum",
  "pl_product_id": "100439000",
  "pozwolenie_nr": "218/20",
  "auth_procedure": "IR",
  "authorisation_validity": "2025-08-25"
}
API referenceMCP serverPlans

See everything about sonstige buccale therapeutika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console